KENS 5: Minorities are desperately needed for clinical trials

Dr. Barbara Taylor, Infectious Diseases, contributed to this second KENS 5 TV news segment on the Novavax trial launch, emphasizing that minorities are desperately needed for clinical trials because the inclusion of diverse groups in trials is the only way to make effective vaccines for all.

Read and watch the story. 



Share This Article!
Article Categories: COVID-19 Media Coverage, In the News